Rate My Professor Phil Taylor

His research elucidates the biology of macrophages and other myeloid cells, focusing on pathogen recognition receptors, inflammation, complement system, cellular origins, development, renewal, and transcriptional regulation. Recent efforts investigate microglia function in Alzheimer's disease, leveraging rare coding variants identified in genome-wide studies, as part of UK DRI at Cardiff where he is a Group Leader. Notable publications include: "Dectin-1 is required for β-glucan recognition and control of fungal infection" (Nature Immunology, 2007, with P.R. Taylor et al.); "The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal" (Science, 2014, with M. Rosas et al.); "Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation" (Nature Communications, 2013); "Tissue-resident macrophages" (Nature Immunology, 2013 review); and recent works like "Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models" (Acta Neuropathologica Communications, 2022). Taylor has received prestigious funding including the MRC PhD studentship, multiple Wellcome Trust awards, and MRC Senior Fellowship. His contributions advance therapeutic manipulation of macrophage activity and promote 3Rs principles in research.